Silver Book Fact

The projected economic value of eliminating deaths from heart disease is approximately $48 trillion.

Murphy, Kevin M. and Robert H. Topel. Measuring the Gains from Medical Research: An economic approach. Chicago, IL: The University of Chicago Press; 2003

Reference

Title
Measuring the Gains from Medical Research: An economic approach
Publisher
The University of Chicago Press
Publication Date
2003
Authors
Murphy, Kevin M. and Robert H. Topel

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Identifying individuals at high risk for developing AFib
    Using simple bedside measures, identification of individuals at risk for developing atrial fibrillation is feasible. Selecting high-risk individuals for inclusion in atrial fibrillation prevention trials may also enhance prevention strategies.  
  • From 1994 to 2004, death rates from cardiovascular disease declined 24.7%.  
  • From 1979 to 2005, the total number of inpatient cardiovascular operations and procedures increased 484% to 6,989,000 annually.  
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.